Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04326660 · ClinicalTrials.gov registry record · NA

SCOPE-Chinese Women Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT04326660 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04326660, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The intervention will be tailored to the participants' behaviors, personal needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children in order to reduce the growing cancer burden in China.

Interventions

  • OTHER SCOPE-Chinese Women

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-07-20
Est. Completion 2021-12-30
Phase NA

What the Registry Record Tells You About NCT04326660

The ClinicalTrials.gov registry entry for NCT04326660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SCOPE-Chinese Women is the first listed.

NCT04326660 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04326660 about?

NCT04326660 is a clinical study titled "SCOPE-Chinese Women Study". This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The interv...

What is the current status of trial NCT04326660?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-07-20. Estimated completion is 2021-12-30.

What interventions are being tested in trial NCT04326660?

The interventions under investigation include: SCOPE-Chinese Women (OTHER).

Who is sponsoring clinical trial NCT04326660?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.